Aleksandra Mieczkowska

Angers, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 21 publications

The GLP-1 analog, exendin-4, improves bone material properties and strength through a central relay in ovariectomized mice.

The GLP-1 analog, exendin-4, improves bone material properties and strength through a central relay in ovariectomized mice.

Journal: American journal of physiology. Endocrinology and metabolism

Published: August 11, 2025

Comprehensive Characterization of Tissue Mineralization in an Ex Vivo Model.

Comprehensive Characterization of Tissue Mineralization in an Ex Vivo Model.

Journal: Journal of visualized experiments : JoVE

Published: October 14, 2024

Validation of Fourier Transform Infrared Microspectroscopy for the Evaluation of Enzymatic Cross-Linking of Bone Collagen.

Validation of Fourier Transform Infrared Microspectroscopy for the Evaluation of Enzymatic Cross-Linking of Bone Collagen.

Journal: Calcified tissue international

Published: March 02, 2023

[Gly²]-GLP-2, But Not Glucagon or [D-Ala²]-GLP-1, Controls Collagen Crosslinking in Murine Osteoblast Cultures.

[Gly²]-GLP-2, But Not Glucagon or [D-Ala²]-GLP-1, Controls Collagen Crosslinking in Murine Osteoblast Cultures.

Journal: Frontiers in endocrinology

Published: June 07, 2021

Dapagliflozin and Liraglutide Therapies Rapidly Enhanced Bone Material Properties and Matrix Biomechanics at Bone Formation Site in a Type 2 Diabetic Mouse Model.

Dapagliflozin and Liraglutide Therapies Rapidly Enhanced Bone Material Properties and Matrix Biomechanics at Bone Formation Site in a Type 2 Diabetic Mouse Model.

Journal: Calcified tissue international

Published: April 06, 2020

GIP analogues augment bone strength by modulating bone composition in diet-induced obesity in mice.

GIP analogues augment bone strength by modulating bone composition in diet-induced obesity in mice.

Journal: Peptides

Published: August 09, 2019

Sitagliptin Alters Bone Composition in High-Fat-Fed Mice.

Sitagliptin Alters Bone Composition in High-Fat-Fed Mice.

Journal: Calcified tissue international

Published: September 25, 2018

The GLP-1 Receptor Agonist Exenatide Ameliorates Bone Composition and Tissue Material Properties in High Fat Fed Diabetic Mice.

The GLP-1 Receptor Agonist Exenatide Ameliorates Bone Composition and Tissue Material Properties in High Fat Fed Diabetic Mice.

Journal: Frontiers in endocrinology

Published: September 20, 2018

Efficacy of targeting bone-specific GIP receptor in ovariectomy-induced bone loss.

Efficacy of targeting bone-specific GIP receptor in ovariectomy-induced bone loss.

Journal: The Journal of endocrinology

Published: July 31, 2018

Glucose-dependent insulinotropic polypeptide (GIP) dose-dependently reduces osteoclast differentiation and resorption.

Glucose-dependent insulinotropic polypeptide (GIP) dose-dependently reduces osteoclast differentiation and resorption.

Journal: Bone

Published: May 26, 2016

A new stable GIP-Oxyntomodulin hybrid peptide improved bone strength both at the organ and tissue levels in genetically-inherited type 2 diabetes mellitus.

A new stable GIP-Oxyntomodulin hybrid peptide improved bone strength both at the organ and tissue levels in genetically-inherited type 2 diabetes mellitus.

Journal: Bone

Published: October 06, 2015

Comparison between quantitative X-ray imaging, dual energy X-ray absorptiometry and microCT in the assessment of bone mineral density in disuse-induced bone loss.

Comparison between quantitative X-ray imaging, dual energy X-ray absorptiometry and microCT in the assessment of bone mineral density in disuse-induced bone loss.

Journal: Journal of musculoskeletal & neuronal interactions

Published: March 03, 2015

Showing 1-12 of 21

Last Updated: 09/26/2026